Safety of Infliximab in Inflammatory Bowel Disease Needs to Be Debated

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	603-604
Journal	Clinical gastroenterology and hepatology
Volume	7
Issue number	5
DOIs	https://doi.org/10.1016/j.cgh.2008.12.021
Publication status	Published - 2009

Access to Document

@article{5a2fcdd17bc34b249bd1069678af275a,

title = "Safety of Infliximab in Inflammatory Bowel Disease Needs to Be Debated",

author = "\{de Vries\}, \{Hilbert S.\} and \{van Oijen\}, \{Martijn G. H.\} and \{de Jong\}, \{Dirk J.\}",

year = "2009",

doi = "10.1016/j.cgh.2008.12.021",

language = "English",

volume = "7",

pages = "603--604",

journal = "Clinical gastroenterology and hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - Safety of Infliximab in Inflammatory Bowel Disease Needs to Be Debated

AU - de Vries, Hilbert S.

AU - van Oijen, Martijn G. H.

AU - de Jong, Dirk J.

PY - 2009

Y1 - 2009

U2 - 10.1016/j.cgh.2008.12.021

DO - 10.1016/j.cgh.2008.12.021

M3 - Comment/Letter to the editor

C2 - 19166980

SN - 1542-3565

VL - 7

SP - 603

EP - 604

JO - Clinical gastroenterology and hepatology

JF - Clinical gastroenterology and hepatology

IS - 5

ER -